<html>
<head>PUBMED IDs for TRID</head>
<body bgcolor='#C5F0F2'><h1>TRID</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7505264/'>P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells.</a> January 2  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8768783/'>Selection of phage-displayed peptides mimicking an extracellular epitope of human MDR1-P-glycoprotein.</a> January 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8768783/'>Selection of phage-displayed peptides mimicking an extracellular epitope of human MDR1-P-glycoprotein.</a> January 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9242610/'>An antagonist decoy receptor and a death domain-containing receptor for TRAIL.</a> August 8  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9441747/'>The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization.</a> January 27  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9563466/'>p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.</a> May 1  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10229846/'>TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege.</a> May 7  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10435597/'>The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.</a> August 6  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10762627/'>Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance.</a> April 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10811986/'>Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/Tax) or MRP (HL60/AR).</a> May 17  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10933923/'>The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.</a> August 10  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11027163/'>An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptogramin-responsive promoters.</a> October 12  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11027095/'>[Sporadic familial meningiomas].</a> October 12  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11279540/'>Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation.</a> March 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12752575/'>Triple A syndrome: genotype-phenotype assessment.</a> May 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15052637/'>New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors.</a> March 31  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15086341/'>Interaction of hairless and thyroid hormone receptor is not involved in the pathogenesis of atrichia with papular lesions.</a> April 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/22374376/'>Concepts of metastasis in flux: the stromal progression model.</a> September 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23027640/'>A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation.</a> June 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24386373/'>WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24912600/'>Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.</a> May 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25292197/'>Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells.</a> September 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25379136/'>Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.</a> November 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25722197/'>Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.</a> February 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26556829/'>ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.</a> May 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26886021/'>Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).</a> December 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26886004/'>Valproic acid-mediated myocardial protection of acute hemorrhagic rat via the BCL-2 pathway.</a> September 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27757308/'>Chemo-immunotherapy mediates durable cure of orthotopic Kras(G12D)/p53(-/-) pancreatic ductal adenocarcinoma.</a> October 21  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27911862/'>Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival.</a> December 3  2016<br></body></html>
